CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31) of $381.96 million as of 2017-12-30, per its 10-K filed 2018-02-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateBenefitObligation · last filed 2018-02-13
- 2017-12-30: Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31) $381.96M.
- 2016-12-31: Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31) $379.94M.
| Period end | Defined Benefit Plan, Plan with Benefit Obligation in Excess of Plan Assets, Benefit Obligation (Deprecated 2018-01-31) |
|---|---|
| 2017-12-30 | $381.96M 10-K · filed 2018-02-13 |
| 2016-12-31 | $379.94M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |